Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

PubWeight™: 3.49‹?› | Rank: Top 1%

🔗 View Article (PMID 16820551)

Published in JAMA on July 05, 2006

Authors

Paul B Watkins1, Neil Kaplowitz, John T Slattery, Connie R Colonese, Salvatore V Colucci, Paul W Stewart, Stephen C Harris

Author Affiliations

1: Department of Medicine, University of North Carolina, Chapel Hill, USA. pbwatkins@med.unc.edu

Associated clinical trials:

Paracetamol Study in Patients With Low Muscle Mass | NCT03648658

Articles citing this

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ (2015) 6.64

The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med (2007) 1.69

Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res (2009) 1.60

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56

Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48

Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology (2013) 1.24

Clinical review: fever in septic ICU patients--friend or foe? Crit Care (2011) 1.21

Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology (2009) 1.19

Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one? J Pharmacol Exp Ther (2009) 1.14

Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study. Toxicol Sci (2010) 1.11

Acute liver failure including acetaminophen overdose. Med Clin North Am (2008) 1.10

Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial. Crit Care Med (2015) 1.10

Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci (2013) 1.07

Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol (2012) 1.05

Alanine aminotransferase-old biomarker and new concept: a review. Int J Med Sci (2014) 1.01

Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res (2011) 1.01

Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat (2007) 1.01

Pharmacologic management of chronic pain. Korean J Pain (2010) 0.99

Pharmacogenomics: a systems approach. Wiley Interdiscip Rev Syst Biol Med (2010) 0.97

Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci (2008) 0.95

Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest (2014) 0.95

The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model. Theor Biol Med Model (2012) 0.94

Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. J Clin Transl Hepatol (2016) 0.93

The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon (2014) 0.93

Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol (2011) 0.93

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults. BMJ Open (2014) 0.91

Paracetamol therapy and outcome of critically ill patients: a multicenter retrospective observational study. Crit Care (2015) 0.90

Acetaminophen-induced acute liver injury in HCV transgenic mice. Toxicol Appl Pharmacol (2012) 0.88

Serum alanine aminotransferase elevation during 10 days of acetaminophen use in nondrinkers. Pharmacotherapy (2010) 0.88

Effectiveness of Chinese massage therapy (Tui Na) for chronic low back pain: study protocol for a randomized controlled trial. Trials (2014) 0.87

Paracetamol: a focus for the general pediatrician. Eur J Pediatr (2013) 0.87

Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury. Genome Med (2013) 0.87

Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med (2010) 0.87

Role of endoplasmic reticulum stress in drug-induced toxicity. Pharmacol Res Perspect (2016) 0.86

Complementary and alternative medicine use in chronic liver disease patients. J Clin Gastroenterol (2010) 0.85

A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol (2014) 0.85

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. Drug Metab Dispos (2013) 0.85

Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J (2012) 0.85

Duloxetine in the management of chronic musculoskeletal pain. Ther Clin Risk Manag (2012) 0.85

Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol (2014) 0.84

Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes. Toxicol Sci (2014) 0.83

Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties. Clin Ophthalmol (2013) 0.83

Acute liver failure after recommended doses of acetaminophen in patients with myopathies. Crit Care Med (2011) 0.83

The proper use of acetaminophen. Paediatr Child Health (2011) 0.82

A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol (2013) 0.80

[Paracetamol. Efficacious and safe for all ages]. Schmerz (2013) 0.80

Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission. PLoS Negl Trop Dis (2016) 0.80

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1. Curr Drug Metab (2015) 0.79

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malar J (2016) 0.79

Effect of therapeutic doses of acetaminophen (up to 4 g/day) on serum alanine aminotransferase levels in subjects consuming ethanol: systematic review and meta-analysis of randomized controlled trials. Pharmacotherapy (2012) 0.78

Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. Regul Toxicol Pharmacol (2015) 0.78

DILI: New Insights into Diagnosis and Management. Curr Hepat Rep (2013) 0.78

Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey. Crit Care (2013) 0.78

Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center. Gastroenterol Hepatol (N Y) (2014) 0.78

Clinical trial data in support of changing guidelines in osteoarthritis treatment. J Pain Res (2014) 0.77

Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver. Toxicol Sci (2015) 0.77

First Multi-gram Preparation SCP-123, A Novel Water Soluble Analgesic. Org Process Res Dev (2009) 0.77

3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity. Toxicol Sci (2011) 0.77

Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol (2015) 0.77

Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice. Cell Death Dis (2016) 0.77

The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role? Biomed Res Int (2015) 0.76

Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation. Hepatology (2015) 0.76

Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. Neuropharmacology (2016) 0.75

Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists. P T (2010) 0.75

Expression Levels of GABA-A Receptor Subunit Alpha 3, Gabra3 and Lipoprotein Lipase, Lpl Are Associated with the Susceptibility to Acetaminophen-Induced Hepatotoxicity. Biomol Ther (Seoul) (2017) 0.75

Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos (2017) 0.75

Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/extended release. J Pain Res (2015) 0.75

From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspective. F1000Res (2016) 0.75

Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med Inform Assoc (2013) 0.75

Competing Mechanistic Hypotheses of Acetaminophen-Induced Hepatotoxicity Challenged by Virtual Experiments. PLoS Comput Biol (2016) 0.75

Liver Effects of Clinical Drugs Differentiated in Human Liver Slices. Int J Mol Sci (2017) 0.75

The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis. J Korean Med Sci (2016) 0.75

Blood gene expression profiling of an early acetaminophen response. Pharmacogenomics J (2016) 0.75

Drug-Induced Liver Injury: Advances in Mechanistic Understanding that will Inform Risk Management. Clin Pharmacol Ther (2016) 0.75

N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice. Fundam Clin Pharmacol (2016) 0.75

Acetaminophen and aminotransferase elevations. JAMA (2006) 0.75

Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant? Gastroenterology (2007) 0.75

Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut (2017) 0.75

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res (2017) 0.75

Articles by these authors

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08

Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS (2007) 4.89

c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology (2006) 3.76

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72

Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology (2006) 3.70

Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology (2003) 3.18

Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem (2008) 3.08

Clinical risk factors for portopulmonary hypertension. Hepatology (2008) 2.62

The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics (2008) 2.54

The road we must take: multidisciplinary team science. Sci Transl Med (2010) 2.51

Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology (2004) 2.26

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood (2002) 2.23

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood (2002) 2.12

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology (2006) 2.12

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain (2007) 2.07

Microarray scanner calibration curves: characteristics and implications. BMC Bioinformatics (2005) 2.02

Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol (2012) 2.00

Drug-induced liver injury. Drug Saf (2007) 1.99

Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol (2006) 1.89

Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr (2007) 1.76

Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology (2003) 1.72

Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood (2003) 1.72

ArrayTrack: an FDA and public genomic tool. Methods Mol Biol (2009) 1.71

Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol (2004) 1.68

Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci (2011) 1.67

Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol Pharmacol (2003) 1.62

Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol (2006) 1.62

ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J Hepatol (2013) 1.61

Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res (2009) 1.60

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. Blood (2003) 1.59

ER stress: can the liver cope? J Hepatol (2006) 1.58

c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem (2011) 1.57

Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med (2008) 1.55

Serum alanine aminotransferase in skeletal muscle diseases. Hepatology (2005) 1.54

Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol Appl Pharmacol (2005) 1.54

Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? Hepatology (2004) 1.51

Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology (2008) 1.50

The contribution of endoplasmic reticulum stress to liver diseases. Hepatology (2011) 1.50

Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr (2007) 1.49

Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res (2005) 1.49

Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain (2005) 1.47

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med (2009) 1.44

Effect of a vascular endothelial cadherin antagonist in a rat lung transplant model. Ann Thorac Surg (2013) 1.43

Re: intravenous versus oral busulfan--perhaps not as different as suggested. Biol Blood Marrow Transplant (2003) 1.41

Immune-mediated drug-induced liver disease. Clin Liver Dis (2002) 1.38

Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem (2010) 1.37

Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5. Clin Pharmacol Ther (2005) 1.35

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology (2009) 1.35

Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol (2006) 1.35

Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology (2004) 1.31

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood (2005) 1.27

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2005) 1.23

Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice. Hepatology (2011) 1.23

Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem (2010) 1.20

Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology (2003) 1.19

Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal (2009) 1.18

Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol (2006) 1.17

Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16

Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol (2010) 1.16

Mechanisms of drug-induced liver disease. Clin Liver Dis (2007) 1.15

Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology (2003) 1.14

Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology (2002) 1.13

Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. Am J Gastroenterol (2005) 1.12

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol (1985) (2003) 1.11

Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med (2006) 1.11

Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta (2012) 1.11

Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults. Clin Drug Investig (2013) 1.10

Mechanism of staurosporine-induced apoptosis in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol (2002) 1.10

Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system. Am J Public Health (2009) 1.09

Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats. Hepatology (2010) 1.08

Cyclophosphamide metabolism is affected by azole antifungals. Blood (2003) 1.08

Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci (2013) 1.07

Growth failure in early life: an important manifestation of Turner syndrome. Horm Res (2002) 1.06

A method for fitting regression splines with varying polynomial order in the linear mixed model. Stat Med (2006) 1.05

Mechanisms of protection by the betaine-homocysteine methyltransferase/betaine system in HepG2 cells and primary mouse hepatocytes. Hepatology (2007) 1.05

An evaluation of HIV testing among inmates in the North Carolina prison system. Am J Public Health (2009) 1.05

Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev (2004) 1.05

Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance. Drug Saf (2003) 1.03

Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab Dispos (2004) 1.01

Regulation of H(2)O(2)-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes. Am J Physiol Cell Physiol (2008) 1.01

Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr (2007) 1.01

Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv (2010) 1.00

Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis. J Proteome Res (2010) 1.00

Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis (2002) 1.00

Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations. J Biol Chem (2012) 0.99

Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver. Hepatology (2002) 0.99

Mechanisms of drug-induced liver injury. Clin Liver Dis (2013) 0.99

Prediction of lung function response for populations exposed to a wide range of ozone conditions. Inhal Toxicol (2012) 0.98

Role of cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 3 (CRTC3) in the initiation of mitochondrial biogenesis and stress response in liver cells. J Biol Chem (2011) 0.98

Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol (2004) 0.98

Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms. J Biol Chem (2007) 0.97

Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver. Alcohol Clin Exp Res (2008) 0.97

Ozone exposure-response model for lung function changes: an alternate variability structure. Inhal Toxicol (2013) 0.97

Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential. J Psychopharmacol (2013) 0.95

Avoiding idiosyncratic DILI: two is better than one. Hepatology (2013) 0.93